ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

INTS Intesity Therapeutics Inc

3,86
-0,14 (-3,50%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Intesity Therapeutics Inc INTS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,14 -3,50% 3,86 23:16:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,95 3,85 3,95 3,86 4,00
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.4.202414:01PRNUSIntensity Therapeutics to Participate in the LD Micro..
26.3.202413:01GLOBEPortage Biotech Completes Monetization of Intensity..
14.3.202421:09PRNUSIntensity Therapeutics Reports Full Year 2023 Financial..
14.3.202413:00PRNUSIntensity Therapeutics to Participate in the 36th Annual..
08.3.202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202400:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202414:01PRNUSIntensity Therapeutics to Present at the 2024 BIO CEO &..
07.2.202422:15EDGAR2Form 8-K - Current report
03.1.202414:01PRNUSIntensity Therapeutics Provides Business Update Reflecting..
12.12.202314:02EDGAR2Form 8-K - Current report
12.12.202314:01PRNUSIntensity Therapeutics Appoints Joseph Talamo, CPA, as Chief..
08.12.202314:30PRNUSIntensity Therapeutics Presents Positive INT230-6 Data in..
01.12.202314:01PRNUSIntensity Therapeutics Selected for Spotlight Oral..
13.11.202318:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202314:02EDGAR2Form 8-K - Current report
13.11.202314:01PRNUSIntensity Therapeutics Reports Third Quarter Financial..
02.11.202312:01PRNUSIntensity Therapeutics Presents Positive INT230-6 Data in..
07.9.202314:01PRNUSIntensity Therapeutics Receives Orphan Drug Designation for..
05.9.202314:01PRNUSIntensity Therapeutics to Present at the H.C. Wainwright..
14.8.202313:01PRNUSIntensity Therapeutics Reports Second Quarter Financial..
07.8.202313:01PRNUSIntensity Therapeutics to Announce Financial Results for the..
10.7.202314:00PRNUSIntensity Therapeutics, Inc. Announces the Closing and Full..
05.7.202322:15PRNUSIntensity Therapeutics, Inc. Announces Closing of Upsized..
30.6.202302:00PRNUSIntensity Therapeutics, Inc. Announces Pricing of Upsized..
06.6.202313:35PRNUSIntensity Therapeutics Reports INT230-6 Can Cause Immune..
03.6.202314:00PRNUSIntensity Therapeutics' INT230-6 Prolongs Survival Alone or..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock